PT1386608E - Agente terapêutico para doença glomerular - Google Patents

Agente terapêutico para doença glomerular Download PDF

Info

Publication number
PT1386608E
PT1386608E PT02720493T PT02720493T PT1386608E PT 1386608 E PT1386608 E PT 1386608E PT 02720493 T PT02720493 T PT 02720493T PT 02720493 T PT02720493 T PT 02720493T PT 1386608 E PT1386608 E PT 1386608E
Authority
PT
Portugal
Prior art keywords
glomerular
glomerular disease
remedial agent
preventive
therapeutic agent
Prior art date
Application number
PT02720493T
Other languages
English (en)
Inventor
Takashi Nakagawa
Makoto Suda
Yoichi Yamauchi
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of PT1386608E publication Critical patent/PT1386608E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT02720493T 2001-04-19 2002-04-18 Agente terapêutico para doença glomerular PT1386608E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001121058 2001-04-19
JP2001361257 2001-11-27
PCT/JP2002/003870 WO2002085363A1 (fr) 2001-04-19 2002-04-18 Agent therapeutique pour soigner la maladie glomerulaire

Publications (1)

Publication Number Publication Date
PT1386608E true PT1386608E (pt) 2011-07-26

Family

ID=26613829

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02720493T PT1386608E (pt) 2001-04-19 2002-04-18 Agente terapêutico para doença glomerular

Country Status (6)

Country Link
US (1) US7504415B2 (pt)
EP (1) EP1386608B1 (pt)
JP (1) JP4235000B2 (pt)
AT (1) ATE511395T1 (pt)
PT (1) PT1386608E (pt)
WO (1) WO2002085363A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE511395T1 (de) 2001-04-19 2011-06-15 Kowa Co Mittel zur behandlung von glomerulopathie
MY131170A (en) * 2002-03-28 2007-07-31 Nissan Chemical Ind Ltd Therapeutic agent for glomerular disease
JPWO2006046528A1 (ja) * 2004-10-29 2008-05-22 興和株式会社 糸球体疾患治療剤
WO2008082537A2 (en) 2006-12-19 2008-07-10 The General Hospital Corporation Compounds for modulating integrin cd11b/cd18
WO2013159082A1 (en) * 2012-04-20 2013-10-24 Adhaere Pharmaceuticals, Inc. Compounds and methods for regulating integrins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1336714C (en) * 1987-08-20 1995-08-15 Yoshihiro Fujikawa Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis
JP2569746B2 (ja) * 1987-08-20 1997-01-08 日産化学工業株式会社 キノリン系メバロノラクトン類
CA2052014A1 (en) 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
JPH08198898A (ja) 1995-01-30 1996-08-06 Takeda Chem Ind Ltd コレステロール搬出促進物質
US6090839A (en) * 1996-12-23 2000-07-18 Merck & Co., Inc. Antidiabetic agents
US6147109A (en) 1997-10-14 2000-11-14 The General Hospital Corporation Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors
CZ20023381A3 (cs) * 2000-04-12 2003-02-12 Novartis Ag Kombinované farmaceutické prostředky obsahující antagonistu AT1-receptoru nebo/a inhibitor HMG-CoA reduktázy nebo/a ACE inhibitor
US6620821B2 (en) * 2000-06-15 2003-09-16 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
EP1314425A4 (en) 2000-08-30 2004-06-02 Sankyo Co MEDICINAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
JPWO2002030425A1 (ja) 2000-10-12 2004-02-19 日産化学工業株式会社 糖尿病合併症予防・治療剤
ATE511395T1 (de) 2001-04-19 2011-06-15 Kowa Co Mittel zur behandlung von glomerulopathie

Also Published As

Publication number Publication date
EP1386608A4 (en) 2005-02-09
ATE511395T1 (de) 2011-06-15
US7504415B2 (en) 2009-03-17
WO2002085363A1 (fr) 2002-10-31
JP4235000B2 (ja) 2009-03-04
EP1386608A1 (en) 2004-02-04
JPWO2002085363A1 (ja) 2004-08-05
US20040116468A1 (en) 2004-06-17
EP1386608B1 (en) 2011-06-01

Similar Documents

Publication Publication Date Title
HK1094425A1 (en) Substituted 2-aminotetralines for the preventive treatment of parkinson's disease
HK1003780A1 (en) Pharmaceutical compositions containing n-(3.4- dimethoxycinnamoyl) anthranilic acid
HK1076816A1 (pt)
HK1082668A1 (en) Remedies for glomerular diseases
DE60104697D1 (de) Sulfonamid-derivate
EP1152004A4 (en) PHOSPHONIC ACID DERIVATIVES HAVING CARBOXYPEPTIDASE B INHIBITOR ACTIVITY
PT1386608E (pt) Agente terapêutico para doença glomerular
SE0101082D0 (sv) Novel use
WO2002064552A8 (en) 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
DK1256581T3 (da) Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitation
IL150965A0 (en) Therapeutic or preventive agent for digestive system diseases containing a diaminotrifluoromethylpyridine derivative
NO20015666L (no) Umiddelbar frigivelses medisinske sammensetninger for oral anvendelse
WO2007000392A3 (en) Chloro-substituted guanidines
BR0214780A (pt) Sal de ácido cìtrico de um composto terapêutico e composições farmacêuticas deste
BR0207307A (pt) Inibidores de glyt-1
NO993911L (no) Remedier/Forebygningsmidler for Õndedrettssykdommer
EP1291349A4 (en) MALTO-OLIGOSACCHARIDE DERIVATIVES AND USE THEREOF
SE0103272D0 (sv) Chemical compounds
EP1393727A4 (en) MEANS FOR THE TREATMENT OF MYELOPATHY
TH51180A (th) วิธีสำหรับการรักษาโรคพาร์คินสันโดยการให้ (-)-5- คีโท-2-N,N-ได-n-โปรพิลอะมิโน-เตตระไฮโดรเตตระลิน